Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C

Biochemical Pharmacology

Volumn 53, Issue 11, 1997, Pages 1597-1604

  Yang, Jin Ming ^a   Sullivan, Gregory F ^a   Hiat, William N ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Breast cancer; Epidermal growth factor receptor; P glycoprotein; Phospholipase C; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN P; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C;

ARTICLE; BREAST CANCER; CELL LINE; ENZYME ACTIVATION; ENZYME ACTIVITY; HYDROLYSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030833608     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)82451-3     Document Type: Article

References (43)

1. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
2. Ford JM and Hait WN, Pharmacologic circumvention of multidrug resistance. Cytotechnology 12: 171-212, 1993.
3. Carlsen SA, Till JE and Ling V, Modulation of drug permeability in Chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteins. Biochim Biophys Acta 467: 238-250, 1977.
4. Garman D, Albers L and Center MS, Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharmacol 32: 3633-3637, 1983.
5. Center MS, Evidence that adriamycin resistance in Chinese hamster lung cells is regulated by phosphorylation of a plasma membrane glycoprotein. Biochem Biophys Res Commun 115: 159-166, 1983.
6. Mellado W and Horwitz SB, Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 26: 6900-6904, 1987.
7. r 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res 47: 2860-2865, 1987.
8. Ma L, Marquardt D, Takemoto L and Center MS, Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593-5599, 1991.
9. Palayoor ST, Stein JM and Hait WN, Inhibition of protein kinase C by antineoplastic agents: Implications for drug resistance. Biochem Biophys Res Commun 148: 718-725, 1987.
10. Chambers TC, Chalikonda I and Eilon G, Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in resistant human cells. Biochem Biohys Res Commun 169: 253-259, 1990.
11. Chambers TC, McAvoy EM, Jacobs JW and Eilon G, Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679-7686, 1990.
12. Aftab DT, Yang JM and Hait WN, Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol Res 6: 59-70, 1994.
13. Chambers TC, Zheng B, and Kuo JF, Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol Pharmacol 41: 1008-1015, 1992.
14. Chambers TC, Pohl J, Raynor RL and Kuo JF, Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J Biol Chem 268: 4592-4595, 1993.
15. Orr GA, Han EK-H, Browne PC, Nieves E, O'Connor BM, Yang C-PH and Horwitz SB, Identification of the major phosphorylation domain of murine mdrlb P-glycoprotein. Analysis of the protein kinase A and protein kinase C phosphorylation sites. J Biol Chem 268:25054-25062, 1993.
16. Yang J-M, Chin K-V and Hait WN, Involvement of phospholipase C in heat-shock-induced phosphorylation of P-glycoprotein in multidrug resistant human breast cancer cells. Biochem Biophys Res Commun 210: 21-30, 1995.
17. Germann UA, Chambers TC, Ambudkar SV, Pastan I and Gottesman MM, Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomembr 27: 53-61, 1995.
18. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH and Glazer RI, Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 3: 181-189, 1991
19. Fine RL, Patel J and Chabner BA, Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586, 1988.
20. Yang JM, Chin KV and Hait WN, Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res 56: 3490-3494, 1996.
21. Meyers MB, Merluzzi VJ, Spengler BA and Biedler JL, Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells. Proc Natl Acad Sci USA 83: 5521-5525, 1986.
22. Meyers MB, Shen WPV, Spengler BA, Ciccarone V, O'Brien JP, Donner DB, Furth ME and Biedler JL, Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells. J Cell Biochem 38: 87-97, 1988.
23. Dickstein B, Valverius EM, Wosikowski K, Saceda M, Pearson JW, Martin MB and Bates SE, Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line. ] Cell Physiol 157: 110-118, 1993.
24. Vickers PJ, Dickson RB, Shoemaker R and Cowan KH, A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol Endocrinol 2: 886-892, 1988.
25. Ullrich A and Schlessinger J, Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
26. Meyers MB, Yu P and Mendelsohn J, Crosstalk between epidermal growth factor receptor and P-glycoprotein in actinomycin D-resistant Chinese hamster lung cells. Biochem Pharmacol 46: 1841-1848, 1993.
27. Doige CA and Sharom FJ, Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim Biophys Acta 1109: 161-171, 1992.
28. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
29. Towbin H, Staehelin T and Gordon J, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
30. Downes P, Hawkins PT and Irvine RF, Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisophosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland. Biochem J 238: 501-506, 1986.
31. Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE and Bell RM, Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras-and sis-transformed normal rat kidney cells. J Biol Chem 261: 8597-8600, 1986.
32. Osborne CK, Hobbs K and Trent JM, Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat 9: 111-121, 1987.
33. Horan Hand P, Colcher D, Salmon D, Ridge J, Noguchi P and Schlom J, Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Cancer Res 45: 833-840, 1985.
34. Carpenter G and Cohen S, Epidermal growth factor. J Biol Chem 265: 7709-7712, 1990.
35. Margolis B, Rhee SG, Felder S, Mervic M, Lyall R, Levitzki A, Ullrich A, Zilberstein A and Schlessinger J, EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGFR signaling. Cell 57: 1101-1107, 1989.
36. Posner I and Levitzki A, Kinetics of phosphorylation of the SH2-containing domain of phospholipase Cγ1 by the epidermal growth factor receptor. FEBS Lett 353: 155-161, 1994.
37. Hait WN and Aftab DT, Rational design and preclinical pharmacology of drugs for reversing multidrug resistance. Biochem Pharmacol 43: 103-107, 1992.
38. Kato S, Nishimura J, Yufu Y, Ideguchi H, Umemura T and Nawata H, Modulation of expression of multidrug resistance gene (mdr-1) by adriamycin. FEBS Lett 308: 175-178, 1992.
39. Lee W-P, P-glycoprotein is hyperphosphorylated in multidrug resistant HOBl lymphoma cells treated with overdose of vincristine. Biochim Biophys Acta 1245: 57-61, 1995.
40. Goodfellow HR, Sardini A, Ruetz S, Callaghan R, Gros P, McNaughton PA and Higgins CF, Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J Biol Chem 271:13668-13674, 1996.
41. Ahmad S, Safa AR and Glazer RI, Modulation of P-glycoprotein by protein kinase Ca in a baculovirus expression system. Biochemistry 33: 10313-10318, 1994.
42. Shalinsky DR, Jekunen AP, Alcaraz JE, Christen RD, Kim S, Khatibi S and Howell SB, Regulation of initial vinblastine influx by P-glycoprotein. Br J Cancer 67: 30-36, 1993.
43. Rohlff C and Glazer RI, Regulation of multidrug resistance through the cAMP and EGF signalling pathways. Cell Signal 7: 431-443, 1995.